Warburg Pincus LLC’s Post

Major Players & Mega Deals Morgan Stanley provided advisory services to Novo Holdings for the announced acquisition of Catalent Pharma Solutions, valued at approximately $16.5 billion. J.P. Morgan, in collaboration with Goldman Sachs, acted as advisers on the buy-side for New Mountain Capital during their announced $5.7 billion acquisition of R1 RCM, a healthcare services provider. Bank of America offered guidance to the purchasing consortium in the announced $12.6 billion acquisition of Truist Life Insurance Services. This deal involved investor groups such as Stone Point Capital, Clayton Dubilier & Rice, and Mubadala. Follow Leverage Shares for more posts like this. #LeverageShares #FinancialAdvisers #Markets Capital at risk.

The integration plan is a roadmap to success. But how do you tailor this roadmap for each unique deal ? Amy M Weck, VP of M&A Integrations at The Liberty Company Insurance Brokers, LLC, unveils the art of crafting adaptable integration plans based on due diligence findings in our recent M&A Science Fall Summit 2023 session. Discover how you can tweak your integration plan for diverse deals in the full session at the link in the comments.👇 #MAScience #MergersAndAcquisitions #MAScienceFallSummit2023

Patterson Companies, Inc. (NASDAQ:PDCO) shares fell more than 6% in early trading on Wednesday after the animal and oral health markets solutions provider reported its first quarter fiscal 2024 financial results. Its sales for the period rose 3.5% year-over-year to $1.57 billion, matching the #WallStreet forecast per #ZacksConsensusEstimate.  Adjusted earnings per share of $0.40 were in line with analysts’ expectations too and represented a 25% increase over the year-ago quarter. #Investors may also have been left disappointed by the fact that the company did not raise its outlook, reiterating its 2024 earnings guidance of $2.14 to $2.24 per share and adjusted earnings guidance of $2.45 to $2.55 per share. #PattersonCompanies #shares were down 6.5% at US$31.16 shortly after the opening bell in New York. More at #Proactive #ProactiveInvestors #NASDAQ #PDCO http://ow.ly/M50h104SGJK

🏥 Private Equity in Healthcare: A Sector-Specific Downturn Recent data from PitchBook highlights a notable trend: Private equity's retreat from certain segments of the healthcare industry is more pronounced than in other sectors. 🔍 Key Insights: 1️⃣ In healthcare services and health-focused IT, deal numbers hit new lows in Q2 2023, plummeting over 70% from their peak in 2021. 2️⃣ Comparatively, PE dealmaking across all sectors has seen a 29% drop since its Q4 2021 high. 3️⃣ A consistent valuation mismatch is hindering deal-making across industries. 4️⃣ In healthcare services, high debt-servicing costs, especially in areas like dental, vision, and veterinary care, are limiting add-on deals. 5️⃣ A notable example of this trend is the dissolution of Carlyle's plan to acquire a stake in Cotiviti, a deal that would've been worth around $15 billion. Furthermore, corporate M&A activity in the healthcare IT sector has slowed even more drastically than PE deals. In H1 2023, only $500 million in deals were made across 37 transactions, a stark contrast to the $44 billion across 134 deals in 2022. The healthcare sector, with its unique challenges and opportunities, is undergoing a significant transformation in the PE landscape. Stakeholders need to be agile and adaptive in this evolving scenario. Read more at: https://lnkd.in/gcXNDS6w #PrivateEquity #HealthcareIndustry #MergersAndAcquisitions #PitchBookData

Thrilled to share that I was selected #1 as part of AdvisorHub’s ‘100 Advisors to Watch’ list. This nationwide recognition measures scope of practice expertise, growth of practice production, leading professionalism, valued client standards and community service. I am thankful to my Valued Clients for allowing me to do what I love. https://lnkd.in/geX3xdc7 2024 AdvisorHub 100 Solo Practice Advisors to Watch The 2024 AdvisorHub 100 Solo Practice Advisors to Watch ranking is based on an algorithm of criteria, focused on three key areas: Quality of Practice, Year-Over-Year Growth, and Professionalism & Character. The rankings weigh the scores in Quality and Growth more heavily than other areas. Time period upon which the rating is based is from 12/31/2022 – 12/31/2023, and was released on 6/20/2024. Advisors considered have a minimum of seven years’ experience, a clean regulatory record with 2 or fewer complaints and no significant judgements, must have been with their current firm for at least two years and in good standing, and have at least $100 million in assets under management. Out of 1,816 total nominations received, 100 advisors received the award. This ranking is not based in any way on the individual's abilities in regards to providing investment advice or management. This ranking is not indicative of advisor’s future performance, is not an endorsement, and may not be representative of individual clients’ experience. Neither Raymond James nor any of its Financial Advisors or RIA firms pay a fee in exchange for this award/rating. Raymond James is not affiliated with AdvisorHub.

The Department of Health and Human Services (HHS) has recently announced a new role, the Chief Competition Officer, to address industry consolidation, competitiveness, and private equity in healthcare. This is definitely a role to keep an eye on! With the new role in place, how this will impact General Catalyst's purchase of Summa Health and other private equity acquisitions. Read more about the new Chief Competition Officer role here: [insert link]

Forager’s Chief Investment Officer, @ForagerSteve discusses the Paragon Care investment thesis, the recent acquisition of CH2, and the potential consequences for the healthcare distribution sector generally. Read the @LivewireMarkets article for the full story: https://bit.ly/4bh7cjK

Continuum showcases its teamwork and sector expertise by advising the Staysure Group on its strategic investment from Intermediate Capital Group (ICG). Founded by entrepreneur Ryan Howsam, the Group has experienced substantial growth and operates a portfolio of insurance brands and products. The Continuum team, led by Garth Hackshall and James Sutton is proud to have played a key role in delivering an outstanding outcome for Ryan and the Staysure team. Read more about the deal in the link in the comments below. #insurance #privateequity #corporatefinance #advisory